A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population

Completed · Phase 4

Conditions studied: Subdural Hematoma

In brief

This is a single center single arm study of 50 patients to 1) determine the safety of tranexamic acid in the chronic subdural hematoma population following surgical drainage of chronic subdural hematomas and 2) determine if the use of oral tranexamic acid reduces the rate of ipsilateral recurrence following drainage of chronic subdural hematomas. This will be compared to historical controls. This study intends to be a prerequisite to a large nationally funded randomized control trial.

Key facts

Study ID
NCT02618382
Run by
St. Joseph's Hospital and Medical Center, Phoenix
People needed
32
Starts
2015-11-01
Expected to finish
2018-06-12
Last updated by the study team
2021-11-11

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.